Deere & Company

Item 5.02 Departure of Directors or Certain Officers, Election of Directors, Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 2, 2026, the Board of Directors (the “Board”) of Deere & Company (the “Company”) increased the size of the Board from ten to eleven directors and appointed Julie Boland to the Board, effective immediately. Ms. Boland will serve as a member of the Compensation Committee and Finance Committee of the Board. Ms. Boland is the former U.S. CEO and Managing Partner and Americas Managing Partner of Ernst & Young LLP (“EY”), a multinational professional services firm providing audit, tax, consulting, and transaction services. She served in numerous leadership roles with EY since 2010, including Vice Chair and Central Region Managing Partner and Cleveland Office Managing Partner. Prior to joining EY, Ms. Boland served as the Chief Financial Officer of both public and private companies. She also has experience in global investment banking with both J.P. Morgan & Co. and Goldman Sachs. The Board believes Ms. Boland's extensive experience in executive leadership, accounting, financial reporting, corporate governance, and global finance will provide a valuable perspective to the Board. Ms. Boland will receive the compensation payable to non-employee directors described in the Company’s definitive proxy statement filed on January 14, 2026, including, on the effective date of her appointment, an automatic initial grant of 92 Restricted Stock Units, and will enter into the Company’s standard director indemnification agreement. There are no arrangements or understandings between Ms. Boland and any other persons pursuant to which Ms. Boland was selected as a director. The Company is not aware of any related party transactions or relationships between Ms. Boland and the Company that would require disclosure under Item 404(a) of Regulation S-K.

Item 7.01 Regulation FD Disclosure. On November 2, 2026, the Company issued a press release relating to Ms. Boland’s appointment, a copy of which is attached hereto and incorporated by reference as Exhibit 99.1. The information in this Item 7.01 is not filed for purposes of the Securities Exchange Act of 1934 and is not deemed incorporated by reference by any general statements incorporating by reference this report or future filings into any filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent the Company specifically incorporates the information by reference.